安究动力第四财季调整后每股亏损0.03美元

华尔街洞察
15 Jul

7月15日,医疗器械企业安究动力(AngioDynamics)公布第四财季财务报告。财报显示当季实现营收8020万美元,调整后EBITDA录得340万美元。本财季毛利率达52.7%,但净利润呈现亏损态势。

具体数据显示,安究动力第四财季净亏损610万美元。经非经常性项目调整后,净亏损额为100万美元,折合每股亏损0.03美元。该业绩表现反映出企业在产品研发投入与市场拓展方面的持续投入。

值得注意的是,尽管营收规模保持稳定,但利润端仍面临挑战。公司管理层在财报中强调,当前战略重点在于推进新型微创介入产品的商业化进程,相关投入对短期利润构成压力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10